WELIREG for certain patients with previously treated advanced RCC
WELIREG for patients with certain VHL disease–associated tumors
Connect with a Merck Associate
Merck is committed to helping you get answers to your questions. Connect with a Merck Associate now. This service is for US health care professionals.
The Merck Access Program
For access, coverage, and dispensing information, visit The Merck Access Program.
CNS = central nervous system; PD-1/L1 = programmed death receptor-1 (PD-1)/programmed death-ligand 1 (PD-L1); pNET = pancreatic neuroendocrine tumors; RCC = renal cell carcinoma; VEGF-TKI = vascular endothelial growth factor tyrosine kinase inhibitor; VHL = von Hippel-Lindau.